Intrinsiqs

Is Protagonist Therapeutics, Inc. overvalued?

Protagonist Therapeutics, Inc. (PTGX) — key valuation metrics and fundamentals.

No verdict
Price
$141.86
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$9.12B
Dividend yield
0.0%
Return on equity
12.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PTGX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.